Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls

Schizophrenia Research

Volumn 97, Issue 1-3, 2007, Pages 6-13

  Esterberg, Michelle L ^a   Jones, Erin M ^a   Compton, Michael T ^b   Walker, Elaine F ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Family members; Nicotine; Schizophrenia; Schizotypy

Indexed keywords

NICOTINE;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENDER; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; NEGATIVE SYNDROME; PHENOTYPE; POSITIVE SYNDROME; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; RELATIVE; RISK FACTOR; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SELF REPORT; SYMPTOM; UNITED STATES;

ADULT; AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SMOKING; SOUTHEASTERN UNITED STATES; STATISTICS AS TOPIC; TOBACCO USE DISORDER;

EID: 36048964548     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.08.024     Document Type: Article

References (53)

1. Aguilar M.C., Gurpegui M., Diaz F.J., and de Leon J. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br. J. Psychiatry 186 (2005) 215-221
2. Allan L.M., Williams J.H., Wellman N.A., Tonin J., Taylor E., Feldon J., and Rawlins J.N.P. Effects of tobacco smoking, schizotypy, and number of pre-exposures on latent inhibition in healthy subjects. Pers. Individ. Differ. 19 (1995) 893-902
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders DSM-IV-TR fourth edition (Text Revision) (2000), American Psychiatric Press, Washington, D.C.
4. Arias H.F., Padin Calo J.J., and Fernandez Gonzalez M.A. Drug use and dependence in schizophrenia. Actas Luso-Esp. Neurol. Psiquiatr. Cienc. Afines 25 (1997) 379-389
5. Asarnow R.F., Nuechterlein K.H., Fogelson D., Subotnik K.L., Payne D.A., Russell A.T., et al. Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study. Arch. Gen. Psychiatry 58 (2001) 581-588
6. Avila M.T., Sherr J.D., Hong E., Myers C.S., and Thaker G.K. Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia. Neuropsychopharmacology 28 (2003) 2184-2191
7. Beratis S., Katrivanou A., and Gourzis P. Factors affecting smoking in schizophrenia. Compr. Psychiatry 42 (2001) 393-402
8. Calkins M.E., Curtis C.E., Grove W.M., and Iacono W.G. Multiple dimensions of schizotypy in first-degree biological relatives of schizophrenia patients. Schizophr. Bull. 30 (2004) 317-325
9. CDC. Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999. Morb. Mort. Wkly. Rep. 51 (2002) 300-303
10. CDC. Annual smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 1997-2001. Morb. Mort. Wkly. Rep. 54 (2005) 625-628
11. Chang B.P., and Lenzenweger M.F. Somatosensory processing and schizophrenia liability: priprioception, exteroceptive, sensitivity, and graphesthesia performance in the biological relatives of schizophrenia patients. J. Abnorm. Psychology 114 (2005) 85-95
12. Dalack G.W., Healy D.J., and Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am. J. Psychiatry 155 (1998) 1490-1501
13. de Leon J. Smoking and vulnerability for schizophrenia. Schizophr. Bull. 22 (1996) 405-409
14. de Leon J., and Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76 (2005) 135-157
15. de Leon J., Mahmood D., Canuso C., White A.O., Stanilla J.K., and Simpson G.M. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry 152 (1995) 453-455
16. de Leon J., Diaz F.J., Aguilar M.C., Jurado D., and Gurpegui M. Does smoking reduce akathisia? Testing a narrow version of the self-medication hypothesis. Schizophr. Res. 86 (2006) 256-268
17. Fanous A., Gardner C., Walsh D., and Kendler K.S. Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Arch. Gen. Psychiatry 58 (2001) 669-673
18. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. New York State Psychiatric Institute (2002), Biometrics Research Department, New York
19. Forchuk C., Norman R., Malla A., Martin M., McLean T., Cheng S., et al. Schizophrenia and the motivation for smoking. Perspect. Psychiatr. Care 38 (2002) 41-49
20. Fukui K., Kobayashi T., Hayakawa S., Koga E., Okazaki S., Kawashima Y., et al. Smoking habits of chronic schizophrenics. Jpn. J. Alc. Stud. Drug Depend. 30 (1995) 447-454
21. George T.P., Seyal A.A., Dolan S.L., Dudas M.M., Termine A., and Vessicchio J.C. Nicotine addiction and schizophrenia: a clinical approach. Prim. Psychiatry 9 (2002) 48-53
22. Goff D.C., Henderson D.C., and Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am. J. Psychiatry 149 (1992) 1189-1194
23. Gray J.A., Mitchell S.N., Joseph M.H., Grigoryan G.A., Dawe S., and Hodges H. Neurochemical mechanisms mediating the behavioural and cognitive effects of nicotine. Drug Dev. Res. 31 (1994) 3-17
24. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., and Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383 (1996) 713-716
25. Hall R.G., Duhamel M., McClanahan R., Miles G., Nason C., Rosen S., Schiller P., Tao-Yonenaga L., and Hall S.M. Level of functioning, severity of illness, and smoking status among chronic psychiatric patients. J. Nerv. Ment. Dis. 183 (1995) 468-471
26. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerstrom K.O. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br. J. Addict. 86 (1991) 1119-1127
27. Herrán A., de Santiago A., Sandoya M., Fernández M.J., Díez-Manrique J.F., and Vázquez- Barquero J.L. Determinants of smoking behaviour in outpatients with schizophrenia. Schizophr. Res. 41 (2000) 373-381
28. Jacobsen L.K., D'Souza D.C., Mencl W.E., Pugh K.R., Skudlarski P., and Krystal J.H. Nicotine effects on brain function and functional connectivity in schizophrenia. Biol. Psychiatry 55 (2004) 850-858
29. Joseph S., Manafi E., Iakovaki A.M., and Cooper R. Personality, smoking motivation, and self-efficacy to quit. Pers. Individ. Differ. 34 (2003) 749-758
30. Kendler K.S., McGuire M., Gruenberg A.M., O'Hare A., Spellman M., and Walsh D. The Roscommon family study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch. Gen. Psychiatry 50 (1993) 527-540
31. Kumari V., and Postma P. Nicotine use in schizophrenia: the self-medication hypothesis. Neurosci. Biobehav. Rev. 29 (2005) 1021-1034
32. Lambe E.K., Picciotto M.R., and Aghajanian G.K. Nicotine induces glutamate release from thalamocortical terminals in prefrontal cortex. Neuropsychopharmacology 28 (2003) 216-225
33. Larrison A.L., Briand K.A., and Sereno A.B. Nicotine, caffeine, alcohol and schizotypy. Pers. Individ. Differ. 27 (1999) 101-108
34. Larrison-Faucher A.L., Matorin A.A., and Sereno A.B. Nicotine reduces antisaccade errors in task impaired schizophrenia subjects. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004) 505-516
35. Lasser K., Wesley B.J., Woolhandler S., Himmestein D.U., McCormick D., and Bor D.H. Smoking and mental illness: a population-based prevalence study. JAMA 284 (2000) 2606-2610
36. Lohr J.B., and Flynn K. Smoking and schizophrenia. Schizophr. Res. 8 (1992) 93-102
37. Lyons M.J., Bar J.L., Kremen W.S., Toomey R., Eisen S.A., Goldberg J., Faraone S.V., and Tsuang M. Nicotine and familial vulnerability to schizophrenia: a discordant twin study. J. Abnorm. Psychology 111 (2002) 687-693
38. Maggini C., and Raballo A. Subjective experience of personality dimensions in 1st degree relatives of schizophrenics. Acta Bio-Med. Ateneo Parm. 74 (2003) 131-136
39. Mata I., Sham P.C., Gilvarry C., Jones P.B., Lewis S.W., and Murray R.M. Childhood schizotypy and positive symptoms in schizophrenic patients predicts schizotypy in relatives. Schizophr. Res. 44 (2000) 129-136
40. Myers C.S., Robles O., Kakoyannis A.N., Sherr J.D., Avila M.T., Blaxton T.A., and Thaker G.K. Nicotine improves delayed recognition in schizophrenia patients. Psychopharmacology 174 (2004) 334-340
41. Patkar A.A., Gopalakrishnan R., Lundy A., Leone F.T., Certa K.M., and Weinstein S.P. Relationship between tobacco smoking and positive and negative symptoms in schizophrenia. J. Nerv. Ment. Dis. 190 (2002) 604-610
42. Raine A. The SPQ: A scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr. Bull. 17 (1991) 556-564
43. Sacco K.A., Termine A., Seyal A., Dudas M.M., Vessicchio J.C., Krishnan-Sarin S., et al. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia. Arch. Gen. Psychiatry 62 (2004) 649-659
44. Schultz S.K., and Andreasen N.C. Schizophrenia. Lancet 353 (1999) 1425-1430
45. Sherr J.D., Myers C.D., Avila M.T., Elliot A., Blaxton T.A., and Thaker G.K. The effects of nicotine on specific eye tracking measures in schizophrenia. Biol. Psychiatry 52 (2002) 721-728
46. Strassnig M., Brar J.S., and Ganguli R. Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia. Schizophr. Res. 86 (2006) 269-275
47. Vollema M.G., Sitskoorn M.M., Appels M.C.M., and Kahn R.S. Does the schizotypal personality questionnaire reflect the biological-genetic vulnerability to schizophrenia?. Schizophr. Res. 54 (2002) 39-45
48. Wiles N.J., Zammit S., Bebbington P., Singleton N., Meltzer H., and Lewis G. Self-reported psychotic symptoms in the general population. Results from the longitudinal study of the British National Psychiatric Morbidity Study. Br. J. Psychiatry 188 (2006) 519-526
49. Williams J.H., Wellman N.A., Allan L.M., Taylor E., Tonin J., Feldon J., and Rawlins J.N.P. Tobacco smoking correlates with schizotypal and borderline personality traits. Pers. Individ. Differ. 20 (1996) 267-270
50. Yaralian P.S., Raine A., Lencz T., Hooley J.M., Bihrle S.E., Mills S., et al. Elevated levels of cognitive-perceptual deficits in individuals with a family history of schizophrenia spectrum disorders. Schizophr. Res. 46 (2000) 57-63
51. Yoshimasu K., and Kiyohara C. Genetic influences on smoking behavior and nicotine dependence: a review. J. Epidemiol. 13 (2003) 183-192
52. Ziedonis D.M., and George T.P. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr. Bull. 23 (1997) 247-254
53. Zeidonis D.M., Kosten T.R., Glazer W.M., and Frances R.J. Nicotine dependence and schizophrenia. Hosp. Community Psychiatry 45 (1994) 204-206